The Story Behind the Cover Picture
The wax liver model at Josephinum
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:358-359
.
(01 June 2025)
Original Article
Intention-to-treat approach for survival benefit of ABO-incompatible living-donor liver transplantation in patients with high Model for End-stage Liver Disease scores
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:360-373
.
(01 June 2025)
PDF
Full Text
(532)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Our intention-to-treat analysis revealed that ABOi-LDLT improved survival for MELD ≥30 patients, over awaiting DDLT in the severe organ shortage regions. ABOi-LDLT demonstrated comparable posttransplant outcomes to ABOc-LDLT and DDLT with acceptable donor complications. ABOi-LDLT is a feasible treatment option in high MELD patients.
Prognostic factors in gallbladder cancer: a comprehensive systematic review and meta-analysis
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:374-397
.
(01 June 2025)
The objective of this study is to identify prognostic factors for GBC post-surgery. Our analysis reveals that factors such as LMR, CA 19-9 level, lymph node status, tumor location, etc., are associated with prognosis, providing valuable insights for clinicians and patients, particularly those facing prognostic challenges.
Evaluating liver resection outcomes post Y90 TARE with personalized dosimetry in intermediate or advanced hepatocellular carcinoma: a focus on surgical and biliary complications
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:398-410
.
(01 June 2025)
PDF
Full Text
(498)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Preliminary reports on liver resection following transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) show promising oncological outcomes. Nonetheless, postoperative biliary complications are underreported. Our retrospective study reveals a 20% bile leak rate, with intervals shorter than 6 months between TARE and surgery posing higher risks.
Splenic hypertrophy predicts liver-specific complications in patients undergoing major liver resection for colorectal liver metastases, after preoperative chemotherapy
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:411-422
.
(01 June 2025)
PDF
Full Text
(299)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Preoperative chemotherapy in colorectal liver metastases (CRLM) improves resectability and survival but may lead to chemotherapy-associated liver injury (CALI). This study links splenic hypertrophy (SH) post-chemotherapy, to postoperative liver-specific complications (LSC) in CRLM patients undergoing major liver resection, suggesting SH as a predictive marker for LSC.
Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:423-441
.
(01 June 2025)
PDF
Full Text
(725)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
The proposed ERAS protocol for LTx in this study can provide a safe management tool to monitor the patient and provide quality service with low morbidities and mortality throughout the observation period.
Review Article
Surgery-related factors for pancreatic fistula after pancreatectomy: an umbrella review
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:442-459
.
(01 June 2025)
This study is the first to conduct an umbrella review that investigated the effect of surgical-related factors on POPF. A citation matrix was combined with AMSTAR2 to identify and select overlapping Mata-Analyses. The GRADE was used to quantify the strength of the evidence.
French Editorial Commentary from the ACHBPT
Stepping forward, treading wisely: a crossed frontier in robotic liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:460-463
.
(01 June 2025)
Editorial Commentary
Beyond estimates: optimizing surgical strategies through accurate blood loss measurement
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:464-466
.
(01 June 2025)
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:467-469
.
(01 June 2025)
Assessing the financial and equity implications of the 2020 liver allocation policy change
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:470-472
.
(01 June 2025)
Expanding the horizons of cytoreductive surgery-hyperthermic intraperitoneal chemotherapy and liver resection for colorectal peritoneal and liver metastases
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:473-475
.
(01 June 2025)
Prognostic effect of surgical margin in patients undergoing hepatectomy for colorectal liver metastasis
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:476-481
.
(01 June 2025)
Three-dimensional (3D) bioprinted co-culture models: a new paradigm for reproducing the tumor microenvironment and precision therapy
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:482-485
.
(01 June 2025)
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:486-489
.
(01 June 2025)
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:490-493
.
(01 June 2025)
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:494-496
.
(01 June 2025)
Navigating the artificial intelligence (AI) era: a paradigm shift in clinical surgical education
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:497-499
.
(01 June 2025)
Emphasis on waiting list management towards better prognosis of all potential liver transplant recipients
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:500-501
.
(01 June 2025)
Editorial
Primary tumor location and KRAS mutation: key prognostic factors in surgically treated colorectal liver metastases
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:502-505
.
(01 June 2025)
Viewpoint
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:506-510
.
(01 June 2025)
Letter to the Editor
Bladder peritoneal flap: a novel approach for pelvic peritoneal reconstruction in complex clinical cases
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:511-514
.
(01 June 2025)
When technology fails: the pivotal role of meticulous clinical reasoning in unmasking an invisible colon cancer mimicking chronic ischemic colitis
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:515-518
.
(01 June 2025)
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:519-521
.
(01 June 2025)
Ectopic hepatocellular carcinoma in the gallbladder
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:522-525
.
(01 June 2025)
Type IVa bile duct dilatation in an adult female treated with living donor liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:526-530
.
(01 June 2025)
Images in Clinical Medicine
An enigmatic abdominal mass presenting 1 year after childbirth
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:531-533
.
(01 June 2025)
Pancreatic developmental biliary cyst
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:534-535
.
(01 June 2025)
Tract hemostasis using radiofrequency ablation for hepatic arterial bleeding after percutaneous transhepatic portal embolization
HepatoBiliary Surgery and Nutrition
2025;
14
(3)
:536-538
.
(01 June 2025)
